Southampton Health Technology Assessments Centre, University of Southampton, UK.
Health Technol Assess. 2010 Jun;14(28):1-192. doi: 10.3310/hta14280.
BACKGROUND: Build-up of earwax is a common reason for attendance in primary care. Current practice for earwax removal generally involves the use of a softening agent, followed by irrigation of the ear if required. However, the safety and benefits of the different methods of removal are not known for certain. OBJECTIVES: To conduct evidence synthesis of the clinical effectiveness and cost-effectiveness of the interventions currently available for softening and/or removing earwax and any adverse events (AEs) associated with the interventions. DATA SOURCES: Eleven electronic resources were searched from inception to November 2008, including: The Cochrane Library; MEDLINE (OVID), PREMEDLINE In-Process & Other Non-Indexed Citations (OVID), EMBASE (OVID); and CINAHL. METHODS: Two reviewers screened titles and abstracts for eligibility. Inclusion criteria were applied to the full text or retrieved papers and data were extracted by two reviewers using data extraction forms developed a priori. Any differences were resolved by discussion or by a third reviewer. Study criteria included: interventions - all methods of earwax removal available and combinations of these methods; participants - adults/children presenting requiring earwax removal; outcomes - measures of hearing, adequacy of clearance of wax, quality of life, time to recurrence or further treatment, AEs and measures of cost-effectiveness; design - randomised controlled trials (RCTs) and controlled clinical trials (CCTs) for clinical effectiveness, cohort studies for AEs and cost-effectiveness, and costing studies for cost-effectiveness. For the economic evaluation, a deterministic decision tree model was developed to evaluate three options: (1) the use of softeners followed by irrigation in primary care; (2) softeners followed by self-irrigation; and (3) a 'no treatment' option. Outcomes were assessed in terms of benefits to patients and costs incurred, with costs presented by exploratory cost-utility analysis. RESULTS: Twenty-six clinical trials conducted in primary care (14 studies), secondary care (8 studies) or other care settings (4 studies), met the inclusion criteria for the review - 22 RCTs and 4 CCTs. The range of interventions included 16 different softeners, with or without irrigation, and in various different comparisons. Participants, outcomes, timing of intervention, follow-up and methodological quality varied between studies. On measures of wax clearance Cerumol, sodium bicarbonate, olive oil and water are all more effective than no treatment; triethanolamine polypeptide (TP) is better than olive oil; wet irrigation is better than dry irrigation; sodium bicarbonate drops followed by irrigation by nurse is more effective than sodium bicarbonate drops followed by self-irrigation; softening with TP and self-irrigation is more effective than self-irrigation only; and endoscopic de-waxing is better than microscopic de-waxing. AEs appeared to be minor and of limited extent. Resuts of the exploratory economic model found that softeners followed by self-irrigation were more likely to be cost-effective [24,433 pounds per quality-adjusted life-year (QALY)] than softeners followed by irrigation at primary care (32,130 pounds per QALY) when compared with no treatment. Comparison of the two active treatments showed that the additional gain associated with softeners followed by irrigation at primary care over softeners followed by self-irrigation was at a cost of 340,000 pounds per QALY. When compared over a lifetime horizon to the 'no treatment' option, the ICERs for softeners followed by self-irrigation and of softeners followed by irrigation at primary care were 24,450 pounds per QALY and 32,136 pounds per QALY, respectively. LIMITATIONS: The systematic review found limited good-quality evidence of the safety, benefits and costs of the different strategies, making it difficult to differentiate between the various methods for removing earwax and rendering the economic evaluation as speculative. CONCLUSIONS: Although softeners are effective, which specific softeners are most effective remains uncertain. Evidence on the effectiveness of methods of irrigation or mechanical removal was equivocal. Further research is required to improve the evidence base, such as a RCT incorporating an economic evaluation to assess the different ways of providing the service, the effectiveness of the different methods of removal and the acceptability of the different approaches to patients and practitioners.
背景:耳垢堆积是导致人们到初级保健机构就诊的常见原因。目前,清除耳垢通常采用软化剂,必要时进行耳部冲洗。但是,对于不同的清除方法的安全性和有效性还没有明确的结论。
目的:对目前可用于软化和/或清除耳垢的干预措施的临床效果和成本效果进行证据综合评价,并评估与干预措施相关的不良事件(AE)。
资料来源:从建立数据库到 2008 年 11 月,共检索了 11 个电子资源,包括:Cochrane 图书馆;MEDLINE(OVID)、PREMEDLINE 处理中和其他非索引引文(OVID)、EMBASE(OVID);和 CINAHL。
方法:两名评审员筛选标题和摘要,以确定是否符合纳入标准。纳入标准适用于全文或检索到的论文,两名评审员使用预先制定的数据提取表提取数据。任何差异都通过讨论或第三名评审员解决。研究标准包括:干预措施——所有可用的耳垢清除方法及其组合;参与者——需要清除耳垢的成年人/儿童;结局指标——听力、清除耳垢的充分性、生活质量、复发或进一步治疗的时间、AE 以及成本效果测量;设计——随机对照试验(RCT)和对照临床试验(CCT)用于临床效果评估,队列研究用于 AE 评估,成本效果评估采用成本效益分析。对于经济评估,开发了一个确定性决策树模型来评估三种选择:(1)在初级保健中使用软化剂,然后进行冲洗;(2)软化剂后进行自我冲洗;(3)“不治疗”选项。评估患者的收益和成本,以探索性成本效益分析呈现成本。
结果:26 项在初级保健(14 项研究)、二级保健(8 项研究)或其他保健环境(4 项研究)中进行的临床试验符合本综述的纳入标准,包括 22 项 RCT 和 4 项 CCT。干预措施的范围包括 16 种不同的软化剂,有或没有冲洗,并且在不同的比较中。参与者、结局、干预时间、随访和方法学质量在研究之间有所不同。在衡量耳垢清除效果方面,Cerumol、碳酸氢钠、橄榄油和水的效果均优于不治疗;三乙醇胺多肽(TP)优于橄榄油;湿冲洗优于干冲洗;碳酸氢钠滴注后由护士进行冲洗比碳酸氢钠滴注后自行冲洗更有效;TP 软化和自行冲洗比仅自行冲洗更有效;内窥镜去蜡比显微镜去蜡更好。AE 似乎是轻微和有限的。探索性经济模型的结果发现,与不治疗相比,在初级保健中使用软化剂后进行自我冲洗更有可能具有成本效益(每质量调整生命年(QALY)24433 英镑),而在初级保健中使用软化剂后进行冲洗则不具有成本效益(每 QALY32130 英镑)。与两种活性治疗相比,在初级保健中使用软化剂后进行冲洗比使用软化剂后进行自我冲洗的额外获益的成本为 340000 英镑/每 QALY。与“不治疗”选项相比,在终身时间范围内,使用软化剂后进行自我冲洗和使用软化剂后进行冲洗的 ICER 分别为 24450 英镑/每 QALY 和 32136 英镑/每 QALY。
局限性:系统评价发现,不同策略的安全性、效果和成本的高质量证据有限,使得难以区分清除耳垢的各种方法,并使经济评价具有推测性。
结论:虽然软化剂是有效的,但哪种软化剂最有效仍然不确定。关于冲洗或机械清除方法的有效性的证据是不确定的。需要进一步的研究来提高证据基础,例如 RCT 纳入经济评估,以评估提供服务的不同方式、不同清除方法的有效性以及患者和从业人员对不同方法的可接受性。
Health Technol Assess. 2010-6
Cochrane Database Syst Rev. 2018-7-25
Cochrane Database Syst Rev. 2003
Audiol Res. 2025-3-19
Indian J Otolaryngol Head Neck Surg. 2024-4
Br J Gen Pract. 2023-1-26
Front Med (Lausanne). 2022-11-15
EClinicalMedicine. 2021-5-8
Diagnostics (Basel). 2020-12-10